BioCorRx Inc.
BICX
$0.2866
-$0.2034-41.51%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -35.55% | -24.05% | -6.13% | 9.94% | 13.79% |
| Total Depreciation and Amortization | -52.40% | 6.68% | 23.74% | 35.94% | 40.94% |
| Total Amortization of Deferred Charges | 71.21% | 130.75% | 96.04% | 54.19% | 30.07% |
| Total Other Non-Cash Items | 262.26% | 29.93% | -51.03% | -60.73% | -68.03% |
| Change in Net Operating Assets | 113.22% | 60.09% | 73.70% | -30.62% | 23.69% |
| Cash from Operations | 40.84% | 21.83% | 22.97% | -14.62% | 9.24% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 16.49% | 22.41% | 16.37% | 10.58% | 25.33% |
| Total Debt Repaid | 65.29% | 70.72% | 95.83% | -5,100.00% | -8,975.00% |
| Issuance of Common Stock | -- | -98.33% | -98.33% | 11.82% | -26.80% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -39.50% | -34.12% | -36.60% | 8.73% | -8.63% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 770.59% | -268.25% | -319.91% | -991.49% | 80.23% |